Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlassRatner Advisory & Capital Group is a national specialty financial advisory firm that provides solutions to complex business problems, including restructuring, forensic accounting, and litigation support. Founded in 2001 and headquartered in Atlanta, the firm was acquired by B. Riley Financial in 2018 and now operates as part of the B. Riley Advisory Services brand. While not a biotechnology or drug development company, GlassRatner maintains a robust healthcare practice area, offering specialized consulting for distressed healthcare providers, hospitals, and senior living facilities. Their services include interim management, valuation, and sell-side representation within the healthcare and middle-market sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlassRatner Advisory & Capital Group.